Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma

By Park Sungshim   Setiawan Veronica   Kanetsky Peter   Zhang Zuo-Feng   Wilkens Lynne   Kolonel Laurence   Marchand Loïc  

Cancer Causes and Control, Vol. 22, Iss. 9, 2011-09 ,pp. : 1267-1275

Springer Publishing Company

Access to resources Recommend Favorite

Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer

By Mathur S.P.   Mathur R.S.   Underwood P.B.   Kohler M.F.   Creasman W.T.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 486-493

Elsevier

Access to resources Recommend Favorite

Circulating levels of insulin-like growth factor II and IGF-binding protein 3 in cervical cancer

By Lovergine Silvia   Masciullo Valeria  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 23-24

Informa Healthcare

Access to resources Recommend Favorite

Relation of serum insulin‐like growth factor‐I (IGF‐I) and IGF binding protein‐3 to risk of prostate cancer (United States)

By Li Li  

Cancer Causes and Control, Vol. 14, Iss. 8, 2003-01 ,pp. : 721-726

Springer Publishing Company

Access to resources Recommend Favorite

Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysis

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 623-628

Science Publishers

Access to resources Recommend Favorite